|
[1]PEERY AF,DELLON ES,LUND J,et al.Burden of gastrointestinal disease in the United States:2012 update[J].Gastroenterology,2012,143(5):1179-1187.
|
|
[2]SIEGEL R,NAISHADHAM D,JEMAL A.Cancer statistics,2013[J].CA Cancer J Clin,2013,63(1):11-30
|
|
[3]MA C,JIANG YX,LIU SZ,et al.Trend and prediction on the incidence of pancreatic cancer in China[J].Chin J Epidemiol,2013,34(2):160-163.(in Chinese)马臣,姜永晓,刘曙正,等.中国胰腺癌发病趋势分析和预测[J].中华流行病学杂志,2013,34(2):160-163.
|
|
[4]ZHANG L,ZHAN Z.Change of TCM tongue coating and syndromes of patients with pancreatic cancer before and after chemotherapy[J].J Changchun Univ Chin Med,2016,32(1):108-110.(in Chinese)张莉,詹7).胰腺癌患者化疗前后中医舌象及证型变化研究[J].长春中医药大学学报,2016,32(1):108-110.
|
|
[5]SZMOLA R,SAHIN-TOTH M.Pancreatitis-associated chymotrypsinogen C(CTRC)mutant elicits endoplasmic reticulum stress in pancreatic acinar cel s[J].Gut,2010,59(3):365-372.
|
|
[6]ROSENDAH J,WITT H,SZMOLA R,et al.Chymotrypsin C(CTRC)variants that diminish activity or secretion are associated with chronic pancreatitis[J].Nat Genet,2008,40(1):78-82.
|
|
[7]WANG H,SHA W,LIN Z,et al.Effect of chymotrypsin C and related proteins on pancreatic cancer cell migration[J].Acta Biochim Biophys Sin(Shanghai),2011,43(5):362-371.
|
|
[8]ZSOFIA NEMODA,MIKLS SAHIN-TTH.Chymotrypsin C(caldecrin)stimulates autoactivation of huaman catonic trypsinogen[J].J Biol Chem,2006,281(17):11879-11886.
|
|
[9]IIO-AKAMA K,SASAMOTO H,MIYAZAWA K,et al.Active forms of chymotrypsin C isolated from autolyzed porcine pancreas glands[J].Biochim Biophys Acta,1985,831(2):249-256.
|
|
[10]BINKER MG,RICHARDS D,GAISANO HY,et al.ER stress-associated CTRC mutants decrease stimulated pancreatic zymogen secretion through SIRT2-mediated microtubule dysregulation[J].Biochem Biophys Res Commun,2015,463(3):329-335.
|
|
[11]NEMODA Z,SAHIN-TOTH M.The tetra-aspartate motif in the activation peptide of human cationictrypsinogen is essential for autoactivation control but not for enteropeptidase recognition[J].J Biol Chem,2005,280(33):29645-29652.
|
|
[12]KEIL-DLOUHA V,PUIGSERVER A,MARIE A,et al.On subunit II of bovine procarboxypeptidase A.Enzymatic specificity after tryptic activation[J].Biochim Biophys Acta,1972,276(2):531-535.
|
|
[13]FOLK JE,COLE PW.ChymotrypsinC.II.Enzymatic specificity toward several polypeptides[J].J Biol Chem,1965,240:193-197.
|
|
[14]SZMOLA R,SAHIN-TOTH M.Chymotrypsin C(caldecrin)promotes degradation of human cationic trypsin:identity with Rinderknecht's enzyme Y[J].Proc Natl Acad Sci U S A,2007,104(27):11227-11232.
|
|
[15]TOMOMURA A,TOMOMURA M,FUKUSHIGE T,et al.Molecular cloning and expression of serum calcium-decreasing factor(caldecrin)[J].J Biol Chem,1995,270(51):30315-30321.
|
|
[16]KOZIEL D,GLUSZEK S,KOWALIK A,et al.Genetic mutations in SPINK1,CFTR,CTRC genes in acute pancreatitis[J].BMC Gastroenterology,2015,15:70.
|
|
[17]PALERMO JJ,LIN TK,HORNUNG L,et al.Genophenotypic analysis of pediatric patients with acute recurrent and chronic pancreatitis[J].Pancreas,2016.[Epub ahead of print]
|
|
[18]WERLIN S,KONIKOFF FM,HALPERN Z,et al.Genetic and electrophysiological characteristics of recurrent acute pancreatitis[J].J Pediatr Gastroenterol Nutr,2015,60(5):675-679.
|
|
[19]LARUSCH J,LOZANO-LEON A,STELLO K,et al.The common chymotrypsinogen C(CTRC)variant G60G(C.180T)increases risk of chronic pancreatitis but not recurrent acute pancreatitis in a North American population[J].Clin Transl Gastroenterol,2015,6:e68.
|
|
[20]TREMBLAY K,DUBOIS-BOUCHARD C,BRISSON D,et al.Association of CTRC and SPINK1 gene variants with recurrent hospitalizations for pancreatitis or acute abdominal pain in lipoprotein lipase deficiency[J].Front Genet,2014,5:90.
|
|
[21]LARUSCH J,WHITCOMB DC.Genetics of pancreatitis[J].Curr Opin Gastroenterol,2011,27(5):467-474.
|
|
[22]RAVI KANTH V,NAGESHWAR REDDY D.Genetics of acute and chronic pancreatitis:an update[J].World J Gastrointest Pathophysiol,2014,5(4):427-437.
|
|
[23]BEER S,ZHOU J,SZABO A,et al.Comprehensive functional analysis of chymotrypsin C(CTRC)variants reveals distinct loss-of-function mechanisms associated with pancreatitis risk[J].Gut,2013,62(11):1616-1624.
|
|
[24]DERIKX MH,DRENTH JP.Drenth genetic factors in chronic pancreatitis;implications for diagnosis,management and prognosis[J].Best Pract Res Clin Gastroenterol,2010,24(3):251-270.
|
|
[25]ZHANG N,WANG YX,HU J,et al.Application of levels of serum CA199,C3,C4 and lipid metabolism in clinical diagnosis of pancreatic cancer[J].J Jilin Univ:Med Edit,2016,42(2):295-300.(in Chinese)张宁,王颖娴,胡健,等.血清CA199、C3、C4及脂类代谢水平在胰腺癌临床诊断中的应用[J].吉林大学学报:医学版,2016,42(2):295-300.
|
|
[26]GUO XZ,LIU X.Discussion of difficult problems of early diagnosis of pancreatic cancer[J].J Clin Hepatol,2014,30(8):734-736.(in Chinese)郭晓钟,刘旭.胰腺癌早期诊断难点的思考[J].临床肝胆病杂志,2014,30(8):734-736.
|
|
[27]PANKOV R,UMEZAWA A,MAKI R,et al.Oncogene activation of human keratin 18 transcription via the Ras signal transduction pathway[J].Proc Natl Acad Sci U S A,1994,91(3):873-877.
|
|
[28]MESSAI Y,NOMAN MZ,DEROUICHE A,et al.Cytokeratin18 expression pattern correlates with renal cell carcinoma progression:relationship with Snail[J].Int J Oncol,2010,36(5):1145-1154.
|
|
[29]STIGBRAND T.The versatility of cytokeratins as tumor markers[J].Tumour Biol,2001,22(1):1-3.
|
|
[30]KULESH DA,OSHIMA RG.Cloning of the human keratin 18gene and its expression in nonepithelial mouse cells[J].Mol Cell Biol,1988,8(4):1540-1550.
|
|
[31]SCHAAFSMA HE,RAMAEKERS FC,van MUIJEN GN,et al.Distribution of cytokeratin polypeptides in human transitional cell carcinomas,with special emphasis on changing expression patterns during tumor progression[J].Am J Pathol,1990,136(2):329-343.
|
|
[32]TRASK DK,BAND V,ZAJCHOWSKI DA,et al.Keratins as markers that distinguish normal and tumor-derived mammary epithelial cells[J].Proc Natl Acad Sci U S A,1990,87(6):2319-2323.
|
|
[33]DEBUS E,MOLL R,FRANKE WW,et al.Immunohistochemical distinction of human carcinomas by cytokeratin typing with monoclonal antibodies[J].Am J Pathol,1984,114(1):121-130.
|
|
[34]CHU YW,YANG PC,YANG SC,et al.Selection of invasive and metastatic subpopulations from a human lung adenocarcinoma cell line[J].Am J Respir Cell Mol Biol,1997,17(3):353-360.
|
|
[35]DIVE C,SMITH RA,GARNER E,et al.Considerations for the use of plasma cytokeratin 18 as a biomarker in pancreatic cancer[J].Br J Cancer,2010,102(3):577-582.
|
DownLoad: